MiR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer

Oncogene

Volumn 34, Issue 31, 2015, Pages 4142-4152

  Gao, J ^a,b   Li, N ^a,b   Dong, Y ^b   Li, S ^a   Xu, L ^b   Li, X ^b   Li, Y ^a   Li, Z ^a   Ng, S S ^b   Sung, J J ^b   Shen, L ^a   Yu, J ^b  

^a Department of Biochemistry and Molecular BiologyCancer Hospital of Peking University   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 7; CASPASE 9; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; INTERSTITIAL COLLAGENASE; KRUPPEL LIKE FACTOR 4; MESSENGER RNA; MICRORNA 34A; MICRORNA 34A 5P; MYC PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NOTCH1 RECEPTOR; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; PROTEIN P27; PROTEIN P53; SIRTUIN 1; SURVIVIN; UNCLASSIFIED DRUG; MICRORNA; MIRN34 MICRORNA, HUMAN; TUMOR MARKER;

3' UNTRANSLATED REGION; ADJUVANT CHEMOTHERAPY; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL MIGRATION; CELL VIABILITY ASSAY; COLONY FORMATION; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENETIC TRANSFECTION; HCT116 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE METASTASIS; MALE; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TUMOR INVASION; TUMOR XENOGRAFT; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; COLORECTAL NEOPLASMS; GENETICS; METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; TUMOR SUPPRESSOR GENE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; COLORECTAL NEOPLASMS; FEMALE; GENES, P53; GENES, TUMOR SUPPRESSOR; HCT116 CELLS; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84938550319     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.348     Document Type: Article

References (37)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Mirakhorli M, Rahman SA, Abdullah S, Vakili M, Rozafzon R, Khoshzaban A. Multidrug resistance protein 2 genetic polymorphism and colorectal cancer recurrence in patients receiving adjuvant FOLFOX-4 chemotherapy. Mol Med Rep 2013; 7: 613-617.
3. Baranwal S, Alahari SK. miRNA control of tumor cell invasion and metastasis. Int J Cancer 2010; 126: 1283-1290.
4. Wang Z, Li Y, Kong D, Ahmad A, Banerjee S, Sarkar FH. Cross-talk between miRNA and Notch signaling pathways in tumor development and progression. Cancer Lett 2010; 292: 141-148.
5. Ma Y, Li W, Wang H. Roles of miRNA in the initiation and development of colorectal carcinoma. Curr Pharm Des 2013; 19: 1253-1261.
6. Dong Y, Wu WKK, Wu CW, Sung JJY, Yu J, Ng SSM. MicroRNA dysregulation in colorectal cancer: a clinical perspective. Br J Cancer 2011; 104: 893-898.
7. Ng EKO, Chong WWS, Jin H, Lam EKY, Shin VY, Yu J et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 2009; 58: 1375-1381.
8. Wu CW, Ng SSM, Dong YJ, Ng SC, Leung WW, Lee CW et al. Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps. Gut 2012; 61: 739-745.
9. Wu CW, Ng SC, Dong Y, Tian L, Ng SSM, Leung WW et al. Identification of microRNA-135b in Stool as a Potential Noninvasive Biomarker for Colorectal Cancer and Adenoma. Clin Cancer Res 2014; 20: 2994-3002.
10. Zhang X, Yan Z, Zhang J, Gong L, Li W, Cui J et al. Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection. Ann Oncol 2011; 22: 2257-2266.
11. Yang M, Shen H, Qiu C, Ni Y, Wang L, Dong W et al. High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer. Eur J Cancer 2013; 49: 604-615.
12. Zhu HT, Dong QZ, Sheng YY, Wei JW, Wang G, Zhou HJ et al. MicroRNA-29a-5p is a novel predictor for early recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection. PLoS One 2012; 7: e52393.
13. Hermeking H. p53 enters the microRNA world. Cancer Cell 2007; 12: 414-418.
14. Yamakuchi M, Lowenstein CJ. MiR-34, SIRT1 and p53: the feedback loop. Cell Cycle 2009; 8: 712-715.
15. Wu J, Wu G, Lv L, Ren Y-F, Zhang X-J, Xue Y-F et al. MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1. Carcinogenesis 2012; 33: 519-528.
16. Ji Q, Hao X, Meng Y, Zhang M, Desano J, Fan D et al. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer 2008; 8: 266.
17. Li N, Fu H, Tie Y, Hu Z, Kong W, Wu Y et al. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Cancer Lett 2009; 275: 44-53.
18. Gallardo E, Navarro A, Viñolas N, Marrades RM, Diaz T, Gel B et al. miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer. Carcinogenesis 2009; 30: 1903-1909.
19. Yamakuchi M, Ferlito M, Lowenstein CJ. miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci USA 2008; 105: 13421-13426.
20. Li L, Yuan L, Luo J, Gao J, Guo J, Xie X. MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1. Clin Exp Med 2013; 13: 109-117.
21. Yamamura S, Saini S, Majid S, Hirata H, Ueno K, Deng G et al. MicroRNA-34a modulates c-Myc transcriptional complexes to suppress malignancy in human prostate cancer cells. PLoS One 2012; 7: e29722.
22. Bu P, Chen KY, Chen JH, Wang L, Walters J, Shin YJ et al. A microRNA miR-34a-regulated bimodal switch targets Notch in colon cancer stem cells. Cell Stem Cell 2013; 12: 602-615.
23. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 2007; 26: 745-752.
24. Leng Z, Tao K, Xia Q, Tan J, Yue Z, Chen J et al. Krüppel-like factor 4 acts as an oncogene in colon cancer stem cell-enriched spheroid cells. PLoS One 2013; 8: e56082.
25. Chen Q, Li L, Tu Y, Zheng LL, Liu W, Zuo XY et al. MiR-34a regulates apoptosis in liver cells by targeting the KLF4 gene. Cell Mol Biol Lett 2014; 19: 52-64.
26. Nair VS, Maeda LS, Ioannidis JPA. Clinical outcome prediction by microRNAs in human cancer: a systematic review. J Natl Cancer Inst 2012; 104: 528-540.
27. Christensen LL, Tobiasen H, Holm A, Schepeler T, Ostenfeld MS, Thorsen K et al. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer. Int J Cancer 2013; 133: 67-78.
28. Yang IP, Tsai HL, Hou MF, Chen KC, Tsai PC, Huang SW et al. MicroRNA-93 inhibits tumor growth and early relapse of human colorectal cancer by affecting genes involved in the cell cycle. Carcinogenesis 2012; 33: 1522-1530.
29. Kjaer-Frifeldt S, Hansen TF, Nielsen BS, Joergensen S, Lindebjerg J, Soerensen FB et al. The prognostic importance of miR-21 in stage II colon cancer: a populationbased study. Br J Cancer 2012; 107: 1169-1174.
30. Mandke P, Wyatt N, Fraser J, Bates B, Berberich SJ, Markey MP. MicroRNA-34a modulates MDM4 expression via a target site in the open reading frame. PLoS One 2012; 7: e42034.
31. Li L, Wang L, Li L, Wang Z, Ho Y, McDonald T et al. Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib. Cancer Cell 2012; 21: 266-281.
32. Li M, Luo J, Brooks CL, Gu W. Acetylation of p53 inhibits its ubiquitination by Mdm2. J Biol Chem 2002; 277: 50607-50611.
33. Sun Y, Wenger L, Rutter JL, Brinckerhoff CE, Cheung HS. p53 down-regulates human matrix metalloproteinase-1 (collagenase-1) gene expression. J Biol Chem 1999; 274: 11535-11540.
34. Tokino T, Nakamura Y. The role of p53-target genes in human cancer. Crit Rev Oncol Hematol 2000; 33: 1-6.
35. Mitrea DM, Yoon M-K, Ou L, Kriwacki RW. Disorder-function relationships for the cell cycle regulatory proteins p21 and p27. Biol Chem 2012; 393: 259-274.
36. Tobiume K. Involvement of Bcl-2 family proteins in p53-induced apoptosis. J Nippon Med Sch 2005; 72: 192-193.
37. Dong Y, Zhao J, Wu CW, Zhang L, Liu X, Kang W et al. Tumor suppressor functions of miR-133a in colorectal cancer. Mol Cancer Res 2013; 11: 1051-1060.